George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Myles:
My understanding is that all three patients in C1 MAY have been dosed at the Royal Marsden.
Whatever the case, give the timing of dosing of the first patient in C1, first dose escalation / second cohort should be due to start anytime now.
Hopefully @avacta #AVCT will update..!
Wow some mark up there!
£14.99 to buy 1 FlowFlex test, but when you want the fit to fly service, it costs £34.99!
https://www.flowflexrapidtest.com/fit-to-fly-testing/
Updated today:
Passengers will need to take a photo of their lateral flow test result and send it back to their private testing provider for verification. Anyone who tests positive will need to self-isolate and take a free NHS confirmatory PCR test.
https://www.gov.uk/government/speeches/summary-of-updates-to-international-travel-october-2021
Given that Richard Hughes helped found and is director of SaturnPass app, its the perfect way to verify test results.
"Users self-test and report their result via our app." Also have about the digital health passport on their website.
I suspect a lot of companies will struggle to find solutions to verify results given the Gov has only announced this less than a week before going live. Randox has just created an app to do so, but very few examples around.
https://www.saturnpass.com
Given we're already selling through the framework via Pro use this is HUGE as doesn't require is to have HUA just yet in order to sell.
Gov saying shortage in supply hence the extension of regulation so step up Medusa!!
Quote:
The government will extend regulations and publish protocol to allow some tests supplied to the private testing market that are pending validation to remain on the market in the short term. This is to address any potential shortage of supply while work continues at pace to ensure only high performing tests are ultimately approved to remain on the UK market. The government will continue to publish a list of private testing providers who meet the minimum standards for the public to choose from,
Given that Medusa Nov last year stated they could produce 50-100m a month, I would say even half of that would be absolutely insane and set the rockets up us! Not long at all to wait now. List is provided on 22nd. Also those who like a chart, weekly is about to turn positive on MACD for first time since May and daily is looking very good too. Given sentiment is returning then this is a brilliant combination and should be seeing some daily rallies from here.
Oddman, its what bbtablet said. Its a total of all the spread bets taken today, which are always posted at 17:07/08, so technically all buys! Couldnt resist and topped up on the spreadbet earlier too after seeing the RSP as was 100k blocks being wanted by MARX all day pushing us up from 113 above 120 etc.
Talking out your backside HP4020. If you're going to attempt to troll, at least get the facts right.
Affidx costs £1-2 to make and sells for £4 direct from Avacta or £4.50 via distributor for pro use. Cost for home use will be more with the profit split agreement with Medusa. No chance Medusa invested tens of millions into upscaling to generate peanuts. They are shrewd and know that supply can't meet the upcoming demand from next week.
Now jog on back to your mums basement where that beach painting in the Bahamas is.
https://twitter.com/boy_cellar/status/1443833117677137958
https://www.patientwing.com/study/386687?showAdvancedDetails=true
Exactly and it's confirmed in the BBC and Gov website etc.
This is definitely what the framework is designed for, orders to Medusa from NHS has just opened up big time from today!
https://www.gov.uk/government/publications/ukhsa-review-into-ipc-guidance/recommendation-2-change-the-pre-procedure-testing-advice-prior-to-elective-procedures-or-planned-care
Thats a load of tosh IFA90.
Calibre had issues early on but as of a couple weeks ago they confirmed that going forward there wont be any more disruptions, and that all orders over a certain size will be sent direct from Avacta, and the smaller orders from Calibre.
Medusa are the dark horse here, they havent invested 10s of millions into the facilities for a small ROI. They have the capacity, and I wouldnt be surprised to see them charge more to get more profit per test considering the switch from PCR to LFTs, which currently most tests are around £30 for one. Even if they charge £10, vastly undercutting rivals, thats potentially £3profit a test for avct alone, with their profit split agreement.
Very promising. Key bit is imo that they still won't allow the free Gov tests to be used, so will be for private companies to fill that hole. In 2019, there were 296 million passengers at UK airports alone, so the figures are huge. Massive open goal for Medusa & Avacta to aim at here. It also forces HUA to be approved, otherwise how will passengers take their tests, would be such a bottleneck!
I think most of us were going off around £1 profit per test, but theres no reason why the profit margin can't be significantly higher for our leading test out there, particularly given the price of others charging £30!
Holidaymakers will still face paying £30 each for supervised lateral flow tests as travel rules are watered down by ministers on Friday.
Under the new rules it is expected that people will not be able to use the free lateral flow tests provided by the Government, so extra costs for travelling will remain.
The travel requirements for the unvaccinated are set to be more expensive, with holidaymakers required to take a Covid test before their flight home, a PCR test on day two after returning and at least a lateral flow test on day eight.
There is speculation that fully-vaccinated arrivals will no longer need to take a pre-departure lateral flow test or a post-arrival PCR test.
Incorrect fiveasypieces
Was updated on the website after close yesterday.
Obviously something has happened yesterday to make it relevant to put up now instead of months ago when they were accepted to the framework. Also being key that they think it's important to put in about the NHS and professional use which AVCT has.
https://twitter.com/tonyg01433365/status/1435364410521006083?s=28
Now go close your short and change your pants as will be some FOMO buying today given all the rumoured news that's due to land very very soon with HUA / EU etc!
What Shandy said. POLB was tipped by "small cap journalist of the year" in the Mail on Sunday with a lengthy article. Likewise has appeared in other newspapers and several websites already. So gained a lot of interest and volume already.
Considering POLB is a small spin off, imagine the publicity that Imutex & DIM will generate.
Cathal and the team are very shrewd and have the right contacts in the right places. Easiest share hold out there with serious upside imho.
Aim2Retire, I would like to think that Medusa will market this well showing the clear differences on why this test is better than others on the market. Hence can charge more. Demand isnt the issue as we know, so a classic supply and demand case where can increase the prices.
Many states in USA a few days ago ran out of stock with demand there going through the roof, and the last time I checked the prices were over $30 for just 1 test (and an average test at that)! So the market is huge, so the profit split between Medusa and Avacta would be fair, and its safe to assume we'd be generating far in excess of £1 per test. Medusa are in this for serious bucks, havent invested tens of millions for a low ROI.
Carlo on Twitter:
Just had a chat with the customer services manager at Bioserve about why my order has been pushed back to 27th Aug. 'Exceptional demand' was said a few times and they've had to place a larger order to try and fulfill that demand
That is on top of the large order they placed for 16th Aug delivery which wasn't enough."
https://twitter.com/Towlie1981/status/1428736641028481030
Ray, if you do some research you'll actually find that...
France
Italy
Portugal
Germany
Greece
& the UK
all accept LFDs for entry. So all you have to do is show your test result to the airline and bingo you're flying!
BA have approx 44m passengers each year, so by the known Medusa capacity as of last year, it would take less than 1 month to produce enough tests for every BA passenger!
Now I'm sure they will be able to flog it onto the extras on the flight page for 10quid and sell nearly everything.
https://twitter.com/LittleGunner5/status/1423209204521836544
Strongly disagree. If a director was to buy now, it would actually be bad news as it would mean no known news is expected in the next month.
A good example is Cathal Friel from ORPH wanted to buy for the last 4 months but as they had a Gov related human challenge study contract in the works, he told investors on a webinar he would buy and be allowed to at the earliest opportunity due to the market rules. He proceeded and bought a couple of weeks ago £300k once news was released, at a higher price than it is currently. The market took it as no big news was due in the next 4ish weeks, hence sold off down and have time to get back in for the rerate.
Given Avacta is waiting on what we all hope is massive news regarding home use / medusa, a director buy right now would raise more questions than showing confidence.
Shocking stuff. Who's signing off on these deals and how many backhanders are they getting?
The current VP used to work for DHSC, so what strings is he pulling?!
https://mobile.twitter.com/SlasherMcGurk/status/1415764927919362049
Quite simple, some clown put in a trade of 1k shares at 130 to mark us down. But we will open up tomorrow at 136.5 where we actually finished.
Funny how all first time posters are coming out the woodwork on here, Twitter etc. Anyone got a feeling that they're employed by Jupiter who are short and are getting worried that the share price is reversing and heading back up? The 130 "finish" was likely them to stir the pot and cause confusion to the average retail investor.
Its all classic games, they're experienced at doing it, going short on many stocks. Just have to look at their performance history vs FTSE & NASDAQ to see how bad they really are!
Best thing would be tomorrow to get a contract RNS and see them scrambling to close their short, would be one massive squeeze and send us even higher with a lack of stock about!
Believe in your investment and don't let derampers make you think otherwise!
Since when was the UK the only market? Agree about protecting capital, but not at these prices, utter madness to sell here with what Avacta have.
"Be fearful when others are greedy and to be greedy only when others are fearful."
Just rewatch the presentation and you'll hear about the demand from Europe and APAC countries.
A lot of rumblings about EU home use soon with Medusa working hard on it. Opens up a huge market. Just have a little bit of patience